You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Praxgen Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for PRAXGEN, and what generic and branded alternatives to PRAXGEN drugs are available?

PRAXGEN has five approved drugs.

Summary for Praxgen

US Patents:	0
Tradenames:	5
Ingredients:	5
NDAs:	5

Drugs and US Patents for Praxgen

+ Get email alerts for changes to this table

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Praxgen	DOXYCYCLINE HYCLATE	doxycycline hyclate	TABLET;ORAL	212487-001	Mar 30, 2022		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Praxgen	METHYLPREDNISOLONE	methylprednisolone	TABLET;ORAL	212262-001	Jun 27, 2019		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Praxgen	LEVOLEUCOVORIN CALCIUM	levoleucovorin calcium	SOLUTION;INTRAVENOUS	213797-001	Nov 2, 2021		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Praxgen	RANOLAZINE	ranolazine	TABLET, EXTENDED RELEASE;ORAL	212781-001	Mar 23, 2020	AB	RX	No	No		⤷ Subscribe				⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.